Improvement of drug safety by the use of lipid-based nanocarriers.
about
Emerging targets and novel approaches to Ebola virus prophylaxis and treatmentSelf-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammationMicellization and Single-Particle Encapsulation with Dimethylammoniopropyl Sulfobetaines.Preclinical studies of N₃-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H₂₂-bearing mice.Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions.Chemo/Dietary prevention of cancer: perspectives in ChinaSide-by-Side Comparison of Commonly Used Biomolecules That Differ in Size and Affinity on Tumor Uptake and Internalization.A novel stearic acid-modified hirudin peptidomimetic with improved pharmacokinetic properties and anticoagulant activity.Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability.Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting ApplicationsUtilisation of nanoparticle technology in cancer chemoresistance.VIP-targeted Cytotoxic Nanomedicine for Breast CancerA novel peptide nanomedicine for treatment of pancreatogenic diabetes.How nanotechnology can enhance docetaxel therapy.Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis.Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.Solubilization of therapeutic agents in micellar nanomedicines.The role of cell cycle in the efficiency and activity of cancer nanomedicines.Strategies for triggered drug release from tumor targeted liposomes.Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy.Approaches to erythrocyte-mediated drug delivery.Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol.iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells.Application of lipid nanoparticles to ocular drug delivery.Superior intratumoral penetration of paclitaxel nanodots strengthens tumor restriction and metastasis prevention.Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.Brain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodents.A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity.Immunostimulatory lipid nanoparticles from herbal medicine.Targeted SLNs for management of HIV-1 associated dementia.Fluorescence-quenching of a liposomal-encapsulated near-infrared fluorophore as a tool for in vivo optical imaging.Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells.Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system.The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation.Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.Novel insights into appropriate encapsulation methods for bioactive compounds into polymers: a study with peptides and HDAC inhibitors.Nanomicelle-Assisted Targeted Ocular Delivery with Enhanced Antiinflammatory Efficacy In Vivo.Cytotoxic, Apoptotic and Genotoxic Effects of Lipid-Based and Polymeric Nano Micelles, an In Vitro Evaluation.Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration.
P2860
Q24597625-354EF629-5705-4028-8BB8-83DE4A587593Q28534642-EA0F8DBC-B671-437E-AB78-4EFB11BEADBFQ33619634-0AEEF54A-2DA0-4486-B1F0-8528158DA18FQ33709579-5036ED15-5C60-416A-BF4E-1211C1CF31DDQ33952771-404FD9FA-453E-47E3-BB9F-A4A2B881D2FDQ34604351-3A31CC4D-F731-49AA-90AD-2BF4C499EA45Q35527009-399E7729-FAF4-4F5A-A3A2-C58FE7361ABAQ36099643-8D638192-2FEC-4CB3-A04B-88E0D709665EQ36379940-BBFEF533-34FA-4CF8-B9FE-2F59E3A330C2Q36408352-17A2059B-004F-417A-86A2-11E90615C14DQ36421258-2A547D1D-7215-47FA-B9A8-1872752B3183Q36538910-B89C95FD-A67E-4DB0-BEC0-E408446BBE29Q36875741-F3A13925-EAAD-449C-A83A-7AEF3E4EA3FAQ37091683-6948907D-9C87-4726-B835-8609F93413E5Q37636279-254E83D3-5348-46DC-A6E3-477A46521646Q37646827-B4D9CCEA-393A-477D-8BAA-2304A5364ED4Q37654928-1E6754A2-D46C-43D4-B3D8-882CE89FBBA4Q38084705-DBFC1583-4274-43D8-9A33-EADA8F6D24F6Q38116638-BC16F156-714D-41C1-B1C5-09D13787FEEBQ38123458-4AE5295B-8D69-4F61-9514-680F9316B6C6Q38189095-03D1C0E8-360E-4244-87EA-11CBCA1905C1Q38716544-467E61B4-579F-4FEA-854B-69DF0E75AEE0Q38836415-6768A85C-30B9-4DF9-A208-D4627A31CAAAQ38862505-A3EDAA2B-1087-4069-8597-2EA00EE66A7DQ38910127-633DE4AB-9D9E-49BA-82C7-89A8495774FDQ39021928-BD65F4F0-27D1-458A-A988-B8E947788AAEQ39438422-A971E2B7-9ACA-4819-9CFE-CBF551968F2DQ40267838-0664B8B4-F7B4-4694-ADB1-7921FC494EDBQ42143518-6CEFB1E6-0F02-4830-A674-99FE0CD5EE02Q42200641-8E8B4D42-3E25-4F76-B186-22370F1EE5DBQ42286003-4E61C46A-0064-4040-95F8-A3B97FFA881CQ42386406-3A7D73D9-EFE6-4C7F-A517-044CD2B5B314Q42620815-14CF05EA-83ED-4D4D-AD26-9620EBD91943Q43801386-0825C547-866F-4B54-B089-3204DB46FBF8Q47190264-B4BA29B4-0107-4FC0-B1D6-11ED7C9508C6Q47677851-E48E91BA-B7A5-40E4-A823-F285BB648434Q47728772-E8EC0F7D-E140-469F-8BC6-650A46174CFCQ48154366-3C33F5C3-0AF7-4453-B381-9D4C1B9957C3Q48309189-1F75043F-1195-4BD4-BD40-C3793F99C5E2Q50618289-069615B3-EC98-4035-9449-746084488CE6
P2860
Improvement of drug safety by the use of lipid-based nanocarriers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Improvement of drug safety by the use of lipid-based nanocarriers.
@en
type
label
Improvement of drug safety by the use of lipid-based nanocarriers.
@en
prefLabel
Improvement of drug safety by the use of lipid-based nanocarriers.
@en
P2093
P1476
Improvement of drug safety by the use of lipid-based nanocarriers.
@en
P2093
Amrita Banerjee
Hayat Önyüksel
Sok Bee Lim
P356
10.1016/J.JCONREL.2012.06.002
P407
P577
2012-06-12T00:00:00Z